December 1, 2008
QUINTILES ACQUIRES
TARGETED MOLECULAR DIAGNOSTICS
Acquisition to enhance Quintiles’ oncology drug development services. www.quintiles.com
May 28, 2008
TARGETED MOLECULAR DIAGNOSTICS INTRODUCES KRAS MUTATION ASSAY TO
IDENTIFY KRAS MUTATIONS IN PATIENTS WITH METASTATIC COLORECTAL CANCER
May 22, 2008
TARGETED MOLECULAR DIAGNOSTICS (TMD) and DxS ANNOUNCE A TIMELY
WORKSHOP ON ASSESSING SOLID TUMOR MUTATIONS
March 19, 2008
TARGETED MOLECULAR DIAGNOSTICS LAUNCHES PHOSPHOGUARDTM - A
PRESERVATIVE FOR PHOSPHORYLATED PROTEINS
November 5, 2007
TARGETED MOLECULAR DIAGNOSTICS INTRODUCES K-ras MUTATION ASSAY TO IDENTIFY
K-ras MUTATIONS IN METASTATIC COLON CANCER PATIENTS
August 29, 2006
TARGETED MOLECULAR DIAGNOSTICS ANNOUNCES NEW PHOSPHOGUARD™ KIT FOR PHOSPHOPROTEIN PRESERVATION
June 26, 2006
NEW EGFR TESTING PROGRAM IMPROVES PATIENT ACCESS TO TARGETED CANCER TREATMENT.
Global News
/
Jul 21, 2005
AutoGenomics and
Targeted Molecular Diagnostics Announce a
Development Partnership for Novel Cancer
Biomarkers for Targeted Therapy.
June 21, 2004 12:00 PM US ET
Targeted
Molecular Diagnostics Announces New
Collaboration with Researchers at University of
Texas M.D. Anderson Cancer Center.
June 26, 2006
Targeted
Molecular Diagnostics Announces New
Collaboration with Researchers at University of
Texas M.D. Anderson Cancer Center.
|
|
|
